KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2017 - 2025)

Biomarin Pharmaceutical (BMRN) has disclosed Interest Coverage Ratio for 16 consecutive years, with 16.06 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Coverage Ratio fell 125.64% year-over-year to 16.06, compared with a TTM value of 37.57 through Dec 2025, down 1.72%, and an annual FY2025 reading of 37.57, down 1.72% over the prior year.
  • Interest Coverage Ratio was 16.06 for Q4 2025 at Biomarin Pharmaceutical, up from 18.1 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 103.35 in Q2 2025 and bottomed at 18.1 in Q3 2025.
  • Average Interest Coverage Ratio over 5 years is 18.86, with a median of 9.11 recorded in 2023.
  • The sharpest move saw Interest Coverage Ratio surged 1663.71% in 2023, then tumbled 147.18% in 2025.
  • Year by year, Interest Coverage Ratio stood at 17.13 in 2021, then surged by 78.93% to 3.61 in 2022, then soared by 290.34% to 6.87 in 2023, then soared by 811.64% to 62.63 in 2024, then tumbled by 125.64% to 16.06 in 2025.
  • Business Quant data shows Interest Coverage Ratio for BMRN at 16.06 in Q4 2025, 18.1 in Q3 2025, and 103.35 in Q2 2025.